Bulevirtide for Chronic Hepatitis D

被引:0
|
作者
Fu, Hua [1 ]
Liu, Yang [1 ]
Liu, Qi [1 ]
机构
[1] Guizhou Med Univ, Affiliated Hosp, Guiyang, Peoples R China
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2023年 / 389卷 / 13期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1247 / 1248
页数:2
相关论文
共 50 条
  • [41] Bulevirtide treatment of hepatitis D in Germany: multicentre real-world experience
    Dietz, Christopher
    Tacke, Frank
    Zoellner, Caroline
    Demir, Munevver
    Schmidt, Hartmut
    Schramm, Christoph
    Willuweit, Katharina
    Lange, Christian M.
    Denk, Gerald
    Weber, Sabine
    Berg, Christoph
    Grottenthaler, Julia
    Merle, Uta
    Olkus, Alexander
    Zeuzem, Stefan
    Sprinzl, Kathrin
    Berg, Thomas
    Wiegand, Johannes
    van Boemmel, Florian
    Herta, Toni
    Seufferlein, Thomas
    Zizer, Eugen
    Dikopoulos, Nektarios
    Thimme, Robert
    Neumann-Haefelin, Christoph
    Galle, Peter
    Sprinzl, Martin
    Lohse, Ansgar W.
    Zur Wiesch, Julian Schulze
    Kempski, Jan
    Geier, Andreas
    Reiter, Florian P.
    Hofmann, Wolf Peter
    Kahlhofer, Julia
    Maasoumy, Benjamin
    Port, Kerstin
    Cornberg, Markus
    Wedemeyer, Heiner
    Deterding, Katja
    JOURNAL OF HEPATOLOGY, 2022, 77 : S823 - S823
  • [42] Demographic, virological and clinical features of patients with chronic hepatitis delta treated with bulevirtide: a multicenter italian study (d-shield)
    Anolli, Maria Paola
    Degasperi, Elisabetta
    D'Offizi, Giampiero
    Rianda, Alessia
    Loglio, Alessandro
    Vigano, Mauro
    Ciancio, Alessia
    Troshina, Yulia
    Brunetto, Maurizia
    Coco, Barbara
    Zaltron, Serena
    Toniutto, Pierluigi
    Marinaro, Letizia
    Gori, Andrea
    Federico, Alessandro
    Santantonio, Teresa
    Verucchi, Gabriella
    Morisco, Filomena
    Mangia, Alessandra
    De Nicola, Stella
    Maracci, Monia
    Romano, Antonietta
    Gatti, Pietro
    Zampino, Rosa
    Persico, Marcello
    Pozzoni, Pietro
    Pellicelli, Adriano
    Coppola, Nicola
    Pileri, Francesca
    Tonnini, Matteo
    Puoti, Massimo
    Lampertico, Pietro
    JOURNAL OF HEPATOLOGY, 2024, 80 : S804 - S804
  • [43] Bulevirtide avoids future clinical events and related costs compared to pegylated-interferon alpha in chronic hepatitis D in Spain
    Buti, Maria
    Calleja Panero, Jose Luis
    Rodriguez Sagrado, Miguel Angel
    Cantero, Helena
    de las Heras, Ana
    Dominguez-Hernandez, Raquel
    Angel Casado, Miguel
    JOURNAL OF HEPATOLOGY, 2022, 77 : S869 - S869
  • [44] Bulevirtide efficacy and safety in chronic hepatitis delta patients on liver transplant waiting list
    Meszaros, Magdalena
    Hilleret, Marie-Noelle
    Dumortier, Jerome
    Dalteroche, Louis
    Abergel, Armand
    Latournerie, Marianne
    Antonini, Teresa
    Conti, Filomena
    Borentain, Patrick
    Kamar, Nassim
    Besch, Camille
    Francoz, Claire
    Debette-Gratien, Maryline
    Dharancy, Sebastien
    Pageaux, Georges-Philippe
    JOURNAL OF HEPATOLOGY, 2024, 80 : S763 - S764
  • [45] EFFECT OF BULEVIRTIDE TREATMENT ON THE HDV INDUCED ANTIVIRAL STATE AND CELL DAMAGE IN INFECTED HUMANIZED MICE AND PATIENTS WITH CHRONIC HEPATITIS D
    Dandri, Maura
    Volz, Tassilo
    Allweiss, Lena
    Manuilov, Dmitry
    Fletcher, Simon
    Holdorf, Meghan
    Muench, Robert
    Downie, Bryan
    Wallin, Jeffrey
    HEPATOLOGY, 2024, 80 : S127 - S127
  • [46] Bulevirtide monotherapy for chronic HDV
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2024, 9 (07): : 597 - 597
  • [47] Treating hepatitis D with bulevirtide-Real-world experience from 114 patients
    Dietz-Fricke, Christopher
    Tacke, Frank
    Zollner, Caroline
    Demir, Munevver
    Schmidt, Hartmut H.
    Schramm, Christoph
    Willuweit, Katharina
    Lange, Christian M.
    Weber, Sabine
    Denk, Gerald
    Berg, Christoph P.
    Grottenthaler, Julia M.
    Merle, Uta
    Olkus, Alexander
    Zeuzem, Stefan
    Sprinzl, Kathrin
    Berg, Thomas
    van Bommel, Florian
    Wiegand, Johannes
    Herta, Toni
    Seufferlein, Thomas
    Zizer, Eugen
    Dikopoulos, Nektarios
    Thimme, Robert
    Neumann-Haefelin, Christoph
    Galle, Peter R.
    Sprinzl, Martin
    Lohse, Ansgar W.
    zur Wiesch, Julian Schulze
    Kempski, Jan
    Geier, Andreas
    Reiter, Florian P.
    Schlevogt, Bernhard
    Goediker, Juliana
    Hofmann, Wolf Peter
    Buggisch, Peter
    Kahlhofer, Julia
    Port, Kerstin
    Maasoumy, Benjamin
    Cornberg, Markus
    Wedemeyer, Heiner
    Deterding, Katja
    JHEP REPORTS, 2023, 5 (04)
  • [48] BULEVIRTIDE MONOTHERAPY IN PATIENTS WITH NON-COMPENSATED LIVER CIRRHOSIS DUE TO HEPATITIS D
    Barsukova, Natalia Alexandrovna
    Bogomolov, Pavel
    Buyeverov, Alexey O.
    Koblov, Sergei
    Isaeva, Ekaterina
    Kalashnikov, Michail Vladislavovich
    Shub, Nadezhda Anatolyevna
    Arapova, Maria Valeryevna
    HEPATOLOGY, 2023, 78 : S2142 - S2142
  • [49] Modeling challenges of hepatitis D virus kinetics during bulevirtide-based therapy
    Mhlanga, Adquate
    Wasserman, Ori
    Lampertico, Pietro
    Cotler, Scott J.
    Dahari, Harel
    JHEP REPORTS, 2025, 7 (02)
  • [50] UNLOCKING THE POTENTIAL: BULEVIRTIDE'S DOSES ON CHRONIC HEPATITIS B VIRUS AND CHRONIC HEPATITIS DELTA VIRUS - A SYSTEMATIC REVIEW AND META-ANALYSIS
    Elghezewi, Abdelwahap
    Hammad, Mohamed
    Mohamed, Mujtaba
    Gamal, Mohamed H.
    Fisal, Khalid M.
    Fathallah, Ahmed H.
    Frandah, Wesam
    GASTROENTEROLOGY, 2024, 166 (05) : S1692 - S1692